Haematological Disease

Haematological Disease

Show other versions (1)

Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Estcourt, L, Stanworth, S, Murphy, M
Fformat:	Book section
Cyhoeddwyd:	John Wiley and Sons 2013

Eitemau Tebyg

Haematological Disease
gan: Murphy, M, et al.
Cyhoeddwyd: (2009)

Platelet transfusions for patients with haematological malignancies: who needs them?
gan: Estcourt, L, et al.
Cyhoeddwyd: (2011)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
gan: Estcourt, L, et al.
Cyhoeddwyd: (2017)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
gan: Estcourt, L, et al.
Cyhoeddwyd: (2016)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
gan: Wardrop, D, et al.
Cyhoeddwyd: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
gan: Wardrop, D, et al.
Cyhoeddwyd: (2013)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
gan: Estcourt, L, et al.
Cyhoeddwyd: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

Prophylactic platelet transfusions
gan: Estcourt, L, et al.
Cyhoeddwyd: (2010)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Estcourt, L, et al.
Cyhoeddwyd: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2015)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2006)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
gan: Stanworth, S, et al.
Cyhoeddwyd: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2014)

2016 National audit of red cell use in adult haematology patients
gan: Karakantza, M, et al.
Cyhoeddwyd: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
gan: Crighton, GL, et al.
Cyhoeddwyd: (2015)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
gan: Butler, C, et al.
Cyhoeddwyd: (2011)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
gan: Crighton, GL, et al.
Cyhoeddwyd: (2021)

Pathogen-reduced platelets for the prevention of bleeding (Review)
gan: Estcourt, L, et al.
Cyhoeddwyd: (2017)

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
gan: Estcourt, L, et al.
Cyhoeddwyd: (2017)

Pathogen-reduced platelets for the prevention of bleeding (Review)
gan: Butler, C, et al.
Cyhoeddwyd: (2013)

Pathogen-reduced platelets for the prevention of bleeding.
gan: Butler, C, et al.
Cyhoeddwyd: (2013)

Transfusion practice and safety: current status and possibilities for improvement.
gan: Murphy, M, et al.
Cyhoeddwyd: (2011)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews 2. Analysis of the combined results from the included studies.
gan: Hyde, C, et al.
Cyhoeddwyd: (2008)

Evidence for indications of fresh frozen plasma.
gan: Stanworth, S, et al.
Cyhoeddwyd: (2007)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews.
gan: Hyde, C, et al.
Cyhoeddwyd: (2008)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
gan: Campbell, H, et al.
Cyhoeddwyd: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
gan: Campbell, H, et al.
Cyhoeddwyd: (2014)

Platelet transfusions in haematology patients: are we using them appropriately?
gan: Estcourt, L, et al.
Cyhoeddwyd: (2012)

Alternatives to allogeneic platelet transfusion
gan: Desborough, M, et al.
Cyhoeddwyd: (2016)

Putting clinical trials into context.
gan: Hyde, C, et al.
Cyhoeddwyd: (2005)